Venneos Overview
- Founded
-
2014
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Venneos General Information
Description
Developer of a silicon-chip-based imaging system designed to analyse biological cells. The company's imaging system helps in the label-free analysis of biological cells and to detect cellular changes which remain invisible with other technologies, enabling researchers to acquire information in areas such as tumor biology, immunology and pharmacology as well as in pharma and biotech companies.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- Nobelstraße 15
- 70569 Stuttgart
- Germany
+49 0711 0000000
Venneos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-May-2018 | 00.000 | Completed | Out of Business | ||
| 3. Early Stage VC (Series A) | 26-Sep-2017 | 00.000 | Completed | Generating Revenue | ||
| 2. Seed Round | 11-Sep-2015 | $1.12M | $1.12M | Completed | Startup | |
| 1. Grant | 13-Jul-2015 | $2.24K | Completed | Startup |
Venneos Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ralf Zeitler | Co-Founder & Managing Director | ||
| Jonas Lehmann | Co-Founder | ||
| Tu Hoang Ph.D | Co-Founder |
Venneos Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
